#United States #Veeva Systems #Boston #AI Innovations #Drug Development

Veeva Summit 2026: Shaping the Future of R&D and Quality in Biopharma

The upcoming Veeva R&D and Quality Summit promises to be a pivotal event in the biopharmaceutical landscape, taking place on October 20-21, 2026, in the vibrant city of Boston. This summit will gather a diverse array of participants, including top biopharmaceutical giants, innovative biotech firms, and contract research organizations (CROs) to explore the latest advancements in drug development and quality assurance powered by artificial intelligence.

At the heart of the summit is Veeva Systems, a prominent player within the industry, which is set to unveil its vision to transform the biopharma sector utilizing deep AI for clinical, regulatory, safety, and quality operations. Key innovations to be featured include the Veeva Falcon agentic labor, the Vault AI agentic platform and agents, and enhanced functionalities within the Veeva Development Cloud and Veeva Quality Cloud applications.

Key Highlights from the Summit

The summit will feature over 100 engaging sessions, showcasing product roadmaps, success stories, and practical insights from industry leaders. Some of the most anticipated topics include:

• - Enhancing Productivity with AI: Learn how Eli Lilly & Company is leveraging artificial intelligence to boost productivity levels, expedite regulatory submissions, and shape the future workforce.
• - Unified Safety Protocols: Gain insights from UCB on developing an integrated safety framework that supports automated case processing and ensures full traceability of data.
• - Connected Clinical Trials: Discover how Duke University and another leading cancer center are implementing scalable, site-centric strategies that deliver direct data from electronic health records (EHR) to electronic data capture (EDC).
• - Patient-first Clinical Ecosystem: Explore how Sanofi is committed to building an interconnected clinical ecosystem aimed at improving the overall trial experience for patients.
• - Modernizing Quality and Manufacturing: Hear from Pfizer, which is experimenting with cloud laboratory information management systems (LIMS) to accelerate the global delivery of medications, paving the way for AI integration.

Networking and Collaboration Opportunities

The Veeva Summit will not only be a learning hub but also a perfect opportunity for networking. With more than 2,500 attendees expected, participants will have the chance to connect with fellow industry professionals, share insights, and forge collaborations that could lead to future advancements in biopharma.

To ensure this event targets the right audience, participation is exclusively for professionals within the life sciences sector. Attendees can register and keep abreast of the schedule through the official Veeva website.

Conclusion

In a rapidly evolving industry, the Veeva R&D and Quality Summit stands as a beacon for innovation in drug development and quality management. With powerful AI tools leading the charge, the summit is set to demonstrate how collaboration and technology can bridge traditional gaps in the biopharma field. With the engagement of key pharmaceutical powerhouses like Pfizer, Eli Lilly, and Sanofi, this event will undoubtedly be a cornerstone for future successes within the sector.

As the pharmaceutical industry continues to transform, events like the Veeva Summit are essential for fostering growth, improving R&D processes, and enhancing quality assurance protocols. Make sure to be part of this remarkable gathering and witness firsthand the innovations that will shape the future of healthcare.